Op-Eds
Removing patent rights to lower drug costs is dangerous precedent
Walter G. Copan Opinion: Removing patent rights to lower drug costs is dangerous precedent The Denver Post
U.S. patent system weakens: Protect IP to keep American tech at the top
Paul R. Michel U.S. patent system weakens: Protect IP to keep American tech at the top VentureBeat
China’s formidable technology challenge
Paul R. Michel https://www.washingtontimes.com/news/2022/mar/16/chinas-formidable-technology-challenge/ The International Business Times
The U.S. must fix its innovation engine: the patent system
Adam Mossoff The U.S. must fix its innovation engine: the patent system STAT
US Economy 2022: Diversity And Inclusion For The Heartland
Paul R. Michel https://www.ibtimes.com/us-economy-2022-diversity-inclusion-heartland-3425396 The International Business Times
Lawmakers want to weaken U.S. patents that made new anti-COVID pills possible. We should do everything to protect them
Andrei Iancu, David Kappos, and Paul R. Michel https://fortune.com/2022/03/04/new-covid-pills-patents-pfizer-merk-ip-pandemic-pharma-health-iancu-kappos-michel/ Fortune
Big Tech is abusing the U.S. patent challenge system
Paul R. Michel https://news.trust.org/item/20220218102516-a1p08 Reuters
Thank You, Senator Tillis, for Recognizing the Need for Evidence-Based Policymaking in Patent Law
Adam Mossoff Thank You, Senator Tillis, for Recognizing the Need for Evidence-Based Policymaking in Patent Law IPWatchdog
The Supreme Court is partly to blame for the Covid-19 test kit shortage
Paul R. Michel The Supreme Court is partly to blame for the Covid-19 test kit shortage STAT (Also published by the Boston Globe)
Can We Please Get Serious About Patents and Drug Pricing?
Barney Cassidy https://www.realclearpolicy.com/articles/2022/01/06/can_we_please_get_serious_about_patents_and_drug_pricing_810732.html RealClearPolicy